Apobank Declares 6 Percent Dividend for 2024

The Deutsche Apotheker- und Ärztebank (Apobank) has announced a dividend of 6 percent for its members based on the financial results of the 2024 fiscal year. This decision was made during the recent representatives' assembly, where the board's proposal received unanimous support.

Matthias Schellenberg, the CEO of Apobank, described 2024 as a significant year for the institution, highlighting its strengthened market position. He noted growth in areas such as the establishment of practices and pharmacies, as well as wealth management, while emphasizing the bank's strategic investments aimed at future development.

Looking ahead to 2025, the bank anticipates maintaining a high level of earnings alongside substantial investments in customer services and technology. However, it is expected that the operational results will be lower than those achieved in 2024. Despite this, the overall annual surplus is projected to remain stable, enabling the bank to provide an attractive dividend to its members. Schellenberg expressed confidence in the bank's trajectory, aiming to position Apobank as the leading financial institution for healthcare professionals.

Additionally, the representatives' assembly welcomed a new member to the supervisory board, Thomas Preis, who takes over from Fritz Becker, the former head of the German Pharmacists' Association (DAV), who did not seek reelection. Karl-Georg Pochhammer, the chairman of the supervisory board, acknowledged Becker's long-standing commitment and contributions to the bank's development during his tenure, which began in 2013.

Andreas Gassen, the head of the National Association of Statutory Health Insurance Physicians (KBV), and Reinhard Urbach from the Dental Association of Lower Saxony have been re-elected to the supervisory board. Pochhammer has also been confirmed again as the chairman of the supervisory board.